 | • レポートコード：MRC2-11QY02364 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、151ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はアルツハイマー病治療法のグローバル市場について調査・分析したレポートです。種類別（ドネペジル、メマンチン、リバスチグミン）市場規模、用途別（初期から中程度段階、中程度から重度段階）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別アルツハイマー病治療法の競争状況、市場シェア ・世界のアルツハイマー病治療法市場：種類別市場規模 2015年-2020年（ドネペジル、メマンチン、リバスチグミン） ・世界のアルツハイマー病治療法市場：種類別市場規模予測 2021年-2026年（ドネペジル、メマンチン、リバスチグミン） ・世界のアルツハイマー病治療法市場：用途別市場規模 2015年-2020年（初期から中程度段階、中程度から重度段階） ・世界のアルツハイマー病治療法市場：用途別市場規模予測 2021年-2026年（初期から中程度段階、中程度から重度段階） ・北米のアルツハイマー病治療法市場分析：米国、カナダ ・ヨーロッパのアルツハイマー病治療法市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのアルツハイマー病治療法市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のアルツハイマー病治療法市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのアルツハイマー病治療法市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Merck &、Novartis AG、Eisai、H. Lundbeck A/S、AC Immune、TauRx Pharmaceuticals、Actavis plc.、Forest Laboratories、Teva Pharmaceuticals Industries、Janssen Pharmaceutical、GE healthcare、Eli Lilly And Company、DiaGenic ASA、VTV Therapeutics、Hoffman-La Roche、AstraZeneca、Daiichi Sankyo Company ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Alzheimer’s disease (AD), also referred to simply as Alzheimer’s, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
Europe is estimated to grow at a rapid pace owing to the high prevalence of AD coupled with ever improving diagnostic capabilities. Asia Pacific is expected to witness the fastest growth over the forecast period owing to the rising disposable income level.
Market Analysis and Insights: Global Alzheimer’s Therapeutics Market
The global Alzheimer’s Therapeutics market size is projected to reach US$ 4905.4 million by 2026, from US$ 4622 million in 2020, at a CAGR of 5.7%% during 2021-2026.
Global Alzheimer’s Therapeutics Scope and Market Size
Alzheimer’s Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alzheimer’s Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Alzheimer’s Therapeutics market is segmented into
Donepezil
Memantine
Rivastigmine
Segment by Application, the Alzheimer’s Therapeutics market is segmented into
Early to Moderate Stages
Moderate to Severe Stages
Regional and Country-level Analysis
The Alzheimer’s Therapeutics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Alzheimer’s Therapeutics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Alzheimer’s Therapeutics Market Share Analysis
Alzheimer’s Therapeutics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Alzheimer’s Therapeutics business, the date to enter into the Alzheimer’s Therapeutics market, Alzheimer’s Therapeutics product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Merck &
Novartis AG
Eisai
H. Lundbeck A/S
AC Immune
TauRx Pharmaceuticals
Actavis plc.
Forest Laboratories
Teva Pharmaceuticals Industries
Janssen Pharmaceutical
GE healthcare
Eli Lilly And Company
DiaGenic ASA
VTV Therapeutics
Hoffman-La Roche
AstraZeneca
Daiichi Sankyo Company
1 Study Coverage
1.1 Alzheimer’s Therapeutics Product Introduction
1.2 Market Segments
1.3 Key Alzheimer’s Therapeutics Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Alzheimer’s Therapeutics Market Size Growth Rate by Type
1.4.2 Donepezil
1.4.3 Memantine
1.4.4 Rivastigmine
1.5 Market by Application
1.5.1 Global Alzheimer’s Therapeutics Market Size Growth Rate by Application
1.5.2 Early to Moderate Stages
1.5.3 Moderate to Severe Stages
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Alzheimer’s Therapeutics Market Size, Estimates and Forecasts
2.1.1 Global Alzheimer’s Therapeutics Revenue 2015-2026
2.1.2 Global Alzheimer’s Therapeutics Sales 2015-2026
2.2 Global Alzheimer’s Therapeutics, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Alzheimer’s Therapeutics Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Alzheimer’s Therapeutics Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Alzheimer’s Therapeutics Competitor Landscape by Players
3.1 Alzheimer’s Therapeutics Sales by Manufacturers
3.1.1 Alzheimer’s Therapeutics Sales by Manufacturers (2015-2020)
3.1.2 Alzheimer’s Therapeutics Sales Market Share by Manufacturers (2015-2020)
3.2 Alzheimer’s Therapeutics Revenue by Manufacturers
3.2.1 Alzheimer’s Therapeutics Revenue by Manufacturers (2015-2020)
3.2.2 Alzheimer’s Therapeutics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Alzheimer’s Therapeutics Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Alzheimer’s Therapeutics Revenue in 2019
3.2.5 Global Alzheimer’s Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Alzheimer’s Therapeutics Price by Manufacturers
3.4 Alzheimer’s Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Alzheimer’s Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Alzheimer’s Therapeutics Product Type
3.4.3 Date of International Manufacturers Enter into Alzheimer’s Therapeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Alzheimer’s Therapeutics Market Size by Type (2015-2020)
4.1.1 Global Alzheimer’s Therapeutics Sales by Type (2015-2020)
4.1.2 Global Alzheimer’s Therapeutics Revenue by Type (2015-2020)
4.1.3 Alzheimer’s Therapeutics Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Alzheimer’s Therapeutics Market Size Forecast by Type (2021-2026)
4.2.1 Global Alzheimer’s Therapeutics Sales Forecast by Type (2021-2026)
4.2.2 Global Alzheimer’s Therapeutics Revenue Forecast by Type (2021-2026)
4.2.3 Alzheimer’s Therapeutics Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Alzheimer’s Therapeutics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Alzheimer’s Therapeutics Market Size by Application (2015-2020)
5.1.1 Global Alzheimer’s Therapeutics Sales by Application (2015-2020)
5.1.2 Global Alzheimer’s Therapeutics Revenue by Application (2015-2020)
5.1.3 Alzheimer’s Therapeutics Price by Application (2015-2020)
5.2 Alzheimer’s Therapeutics Market Size Forecast by Application (2021-2026)
5.2.1 Global Alzheimer’s Therapeutics Sales Forecast by Application (2021-2026)
5.2.2 Global Alzheimer’s Therapeutics Revenue Forecast by Application (2021-2026)
5.2.3 Global Alzheimer’s Therapeutics Price Forecast by Application (2021-2026)
6 North America
6.1 North America Alzheimer’s Therapeutics by Country
6.1.1 North America Alzheimer’s Therapeutics Sales by Country
6.1.2 North America Alzheimer’s Therapeutics Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Alzheimer’s Therapeutics Market Facts & Figures by Type
6.3 North America Alzheimer’s Therapeutics Market Facts & Figures by Application
7 Europe
7.1 Europe Alzheimer’s Therapeutics by Country
7.1.1 Europe Alzheimer’s Therapeutics Sales by Country
7.1.2 Europe Alzheimer’s Therapeutics Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Alzheimer’s Therapeutics Market Facts & Figures by Type
7.3 Europe Alzheimer’s Therapeutics Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Alzheimer’s Therapeutics by Region
8.1.1 Asia Pacific Alzheimer’s Therapeutics Sales by Region
8.1.2 Asia Pacific Alzheimer’s Therapeutics Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Alzheimer’s Therapeutics Market Facts & Figures by Type
8.3 Asia Pacific Alzheimer’s Therapeutics Market Facts & Figures by Application
9 Latin America
9.1 Latin America Alzheimer’s Therapeutics by Country
9.1.1 Latin America Alzheimer’s Therapeutics Sales by Country
9.1.2 Latin America Alzheimer’s Therapeutics Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Alzheimer’s Therapeutics Market Facts & Figures by Type
9.3 Central & South America Alzheimer’s Therapeutics Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Alzheimer’s Therapeutics by Country
10.1.1 Middle East and Africa Alzheimer’s Therapeutics Sales by Country
10.1.2 Middle East and Africa Alzheimer’s Therapeutics Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Alzheimer’s Therapeutics Market Facts & Figures by Type
10.3 Middle East and Africa Alzheimer’s Therapeutics Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Alzheimer’s Therapeutics Products Offered
11.1.5 Pfizer Related Developments
11.2 Merck &
11.2.1 Merck & Corporation Information
11.2.2 Merck & Description and Business Overview
11.2.3 Merck & Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck & Alzheimer’s Therapeutics Products Offered
11.2.5 Merck & Related Developments
11.3 Novartis AG
11.3.1 Novartis AG Corporation Information
11.3.2 Novartis AG Description and Business Overview
11.3.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis AG Alzheimer’s Therapeutics Products Offered
11.3.5 Novartis AG Related Developments
11.4 Eisai
11.4.1 Eisai Corporation Information
11.4.2 Eisai Description and Business Overview
11.4.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Eisai Alzheimer’s Therapeutics Products Offered
11.4.5 Eisai Related Developments
11.5 H. Lundbeck A/S
11.5.1 H. Lundbeck A/S Corporation Information
11.5.2 H. Lundbeck A/S Description and Business Overview
11.5.3 H. Lundbeck A/S Sales, Revenue and Gross Margin (2015-2020)
11.5.4 H. Lundbeck A/S Alzheimer’s Therapeutics Products Offered
11.5.5 H. Lundbeck A/S Related Developments
11.6 AC Immune
11.6.1 AC Immune Corporation Information
11.6.2 AC Immune Description and Business Overview
11.6.3 AC Immune Sales, Revenue and Gross Margin (2015-2020)
11.6.4 AC Immune Alzheimer’s Therapeutics Products Offered
11.6.5 AC Immune Related Developments
11.7 TauRx Pharmaceuticals
11.7.1 TauRx Pharmaceuticals Corporation Information
11.7.2 TauRx Pharmaceuticals Description and Business Overview
11.7.3 TauRx Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 TauRx Pharmaceuticals Alzheimer’s Therapeutics Products Offered
11.7.5 TauRx Pharmaceuticals Related Developments
11.8 Actavis plc.
11.8.1 Actavis plc. Corporation Information
11.8.2 Actavis plc. Description and Business Overview
11.8.3 Actavis plc. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Actavis plc. Alzheimer’s Therapeutics Products Offered
11.8.5 Actavis plc. Related Developments
11.9 Forest Laboratories
11.9.1 Forest Laboratories Corporation Information
11.9.2 Forest Laboratories Description and Business Overview
11.9.3 Forest Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Forest Laboratories Alzheimer’s Therapeutics Products Offered
11.9.5 Forest Laboratories Related Developments
11.10 Teva Pharmaceuticals Industries
11.10.1 Teva Pharmaceuticals Industries Corporation Information
11.10.2 Teva Pharmaceuticals Industries Description and Business Overview
11.10.3 Teva Pharmaceuticals Industries Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Teva Pharmaceuticals Industries Alzheimer’s Therapeutics Products Offered
11.10.5 Teva Pharmaceuticals Industries Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Alzheimer’s Therapeutics Products Offered
11.1.5 Pfizer Related Developments
11.12 GE healthcare
11.12.1 GE healthcare Corporation Information
11.12.2 GE healthcare Description and Business Overview
11.12.3 GE healthcare Sales, Revenue and Gross Margin (2015-2020)
11.12.4 GE healthcare Products Offered
11.12.5 GE healthcare Related Developments
11.13 Eli Lilly And Company
11.13.1 Eli Lilly And Company Corporation Information
11.13.2 Eli Lilly And Company Description and Business Overview
11.13.3 Eli Lilly And Company Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Eli Lilly And Company Products Offered
11.13.5 Eli Lilly And Company Related Developments
11.14 DiaGenic ASA
11.14.1 DiaGenic ASA Corporation Information
11.14.2 DiaGenic ASA Description and Business Overview
11.14.3 DiaGenic ASA Sales, Revenue and Gross Margin (2015-2020)
11.14.4 DiaGenic ASA Products Offered
11.14.5 DiaGenic ASA Related Developments
11.15 VTV Therapeutics
11.15.1 VTV Therapeutics Corporation Information
11.15.2 VTV Therapeutics Description and Business Overview
11.15.3 VTV Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.15.4 VTV Therapeutics Products Offered
11.15.5 VTV Therapeutics Related Developments
11.16 Hoffman-La Roche
11.16.1 Hoffman-La Roche Corporation Information
11.16.2 Hoffman-La Roche Description and Business Overview
11.16.3 Hoffman-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Hoffman-La Roche Products Offered
11.16.5 Hoffman-La Roche Related Developments
11.17 AstraZeneca
11.17.1 AstraZeneca Corporation Information
11.17.2 AstraZeneca Description and Business Overview
11.17.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.17.4 AstraZeneca Products Offered
11.17.5 AstraZeneca Related Developments
11.18 Daiichi Sankyo Company
11.18.1 Daiichi Sankyo Company Corporation Information
11.18.2 Daiichi Sankyo Company Description and Business Overview
11.18.3 Daiichi Sankyo Company Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Daiichi Sankyo Company Products Offered
11.18.5 Daiichi Sankyo Company Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Alzheimer’s Therapeutics Market Estimates and Projections by Region
12.1.1 Global Alzheimer’s Therapeutics Sales Forecast by Regions 2021-2026
12.1.2 Global Alzheimer’s Therapeutics Revenue Forecast by Regions 2021-2026
12.2 North America Alzheimer’s Therapeutics Market Size Forecast (2021-2026)
12.2.1 North America: Alzheimer’s Therapeutics Sales Forecast (2021-2026)
12.2.2 North America: Alzheimer’s Therapeutics Revenue Forecast (2021-2026)
12.2.3 North America: Alzheimer’s Therapeutics Market Size Forecast by Country (2021-2026)
12.3 Europe Alzheimer’s Therapeutics Market Size Forecast (2021-2026)
12.3.1 Europe: Alzheimer’s Therapeutics Sales Forecast (2021-2026)
12.3.2 Europe: Alzheimer’s Therapeutics Revenue Forecast (2021-2026)
12.3.3 Europe: Alzheimer’s Therapeutics Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Alzheimer’s Therapeutics Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Alzheimer’s Therapeutics Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Alzheimer’s Therapeutics Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Alzheimer’s Therapeutics Market Size Forecast by Region (2021-2026)
12.5 Latin America Alzheimer’s Therapeutics Market Size Forecast (2021-2026)
12.5.1 Latin America: Alzheimer’s Therapeutics Sales Forecast (2021-2026)
12.5.2 Latin America: Alzheimer’s Therapeutics Revenue Forecast (2021-2026)
12.5.3 Latin America: Alzheimer’s Therapeutics Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Alzheimer’s Therapeutics Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Alzheimer’s Therapeutics Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Alzheimer’s Therapeutics Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Alzheimer’s Therapeutics Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Alzheimer’s Therapeutics Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Alzheimer’s Therapeutics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Alzheimer’s Therapeutics Market Segments
Table 2. Ranking of Global Top Alzheimer’s Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Alzheimer’s Therapeutics Market Size Growth Rate by Type 2020-2026 (M Units) & (US$ Million)
Table 4. Major Manufacturers of Donepezil
Table 5. Major Manufacturers of Memantine
Table 6. Major Manufacturers of Rivastigmine
Table 7. Global Alzheimer’s Therapeutics Market Size Growth Rate by Application 2020-2026 (M Units)
Table 8. Global Alzheimer’s Therapeutics Market Size by Region (M Units) & (US$ Million): 2020 VS 2026
Table 9. Global Alzheimer’s Therapeutics Sales by Regions 2015-2020 (M Units)
Table 10. Global Alzheimer’s Therapeutics Sales Market Share by Regions (2015-2020)
Table 11. Global Alzheimer’s Therapeutics Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Alzheimer’s Therapeutics Sales by Manufacturers (2015-2020) (M Units)
Table 13. Global Alzheimer’s Therapeutics Sales Share by Manufacturers (2015-2020)
Table 14. Global Alzheimer’s Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Alzheimer’s Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer’s Therapeutics as of 2019)
Table 16. Alzheimer’s Therapeutics Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Alzheimer’s Therapeutics Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Alzheimer’s Therapeutics Price (2015-2020) (USD/Unit)
Table 19. Alzheimer’s Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Alzheimer’s Therapeutics Product Type
Table 21. Date of International Manufacturers Enter into Alzheimer’s Therapeutics Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Alzheimer’s Therapeutics Sales by Type (2015-2020) (M Units)
Table 24. Global Alzheimer’s Therapeutics Sales Share by Type (2015-2020)
Table 25. Global Alzheimer’s Therapeutics Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Alzheimer’s Therapeutics Revenue Share by Type (2015-2020)
Table 27. Alzheimer’s Therapeutics Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Alzheimer’s Therapeutics Sales by Application (2015-2020) (M Units)
Table 29. Global Alzheimer’s Therapeutics Sales Share by Application (2015-2020)
Table 30. North America Alzheimer’s Therapeutics Sales by Country (2015-2020) (M Units)
Table 31. North America Alzheimer’s Therapeutics Sales Market Share by Country (2015-2020)
Table 32. North America Alzheimer’s Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Alzheimer’s Therapeutics Revenue Market Share by Country (2015-2020)
Table 34. North America Alzheimer’s Therapeutics Sales by Type (2015-2020) (M Units)
Table 35. North America Alzheimer’s Therapeutics Sales Market Share by Type (2015-2020)
Table 36. North America Alzheimer’s Therapeutics Sales by Application (2015-2020) (M Units)
Table 37. North America Alzheimer’s Therapeutics Sales Market Share by Application (2015-2020)
Table 38. Europe Alzheimer’s Therapeutics Sales by Country (2015-2020) (M Units)
Table 39. Europe Alzheimer’s Therapeutics Sales Market Share by Country (2015-2020)
Table 40. Europe Alzheimer’s Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Alzheimer’s Therapeutics Revenue Market Share by Country (2015-2020)
Table 42. Europe Alzheimer’s Therapeutics Sales by Type (2015-2020) (M Units)
Table 43. Europe Alzheimer’s Therapeutics Sales Market Share by Type (2015-2020)
Table 44. Europe Alzheimer’s Therapeutics Sales by Application (2015-2020) (M Units)
Table 45. Europe Alzheimer’s Therapeutics Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Alzheimer’s Therapeutics Sales by Region (2015-2020) (M Units)
Table 47. Asia Pacific Alzheimer’s Therapeutics Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Alzheimer’s Therapeutics Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Alzheimer’s Therapeutics Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Alzheimer’s Therapeutics Sales by Type (2015-2020) (M Units)
Table 51. Asia Pacific Alzheimer’s Therapeutics Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Alzheimer’s Therapeutics Sales by Application (2015-2020) (M Units)
Table 53. Asia Pacific Alzheimer’s Therapeutics Sales Market Share by Application (2015-2020)
Table 54. Latin America Alzheimer’s Therapeutics Sales by Country (2015-2020) (M Units)
Table 55. Latin America Alzheimer’s Therapeutics Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Alzheimer’s Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Alzheimer’s Therapeutics Revenue Market Share by Country (2015-2020)
Table 58. Latin America Alzheimer’s Therapeutics Sales by Type (2015-2020) (M Units)
Table 59. Latin America Alzheimer’s Therapeutics Sales Market Share by Type (2015-2020)
Table 60. Latin America Alzheimer’s Therapeutics Sales by Application (2015-2020) (M Units)
Table 61. Latin America Alzheimer’s Therapeutics Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Alzheimer’s Therapeutics Sales by Country (2015-2020) (M Units)
Table 63. Middle East and Africa Alzheimer’s Therapeutics Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Alzheimer’s Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Alzheimer’s Therapeutics Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Alzheimer’s Therapeutics Sales by Type (2015-2020) (M Units)
Table 67. Middle East and Africa Alzheimer’s Therapeutics Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Alzheimer’s Therapeutics Sales by Application (2015-2020) (M Units)
Table 69. Middle East and Africa Alzheimer’s Therapeutics Sales Market Share by Application (2015-2020)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Major Businesses
Table 72. Pfizer Alzheimer’s Therapeutics Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Pfizer Product
Table 74. Pfizer Recent Development
Table 75. Merck & Corporation Information
Table 76. Merck & Description and Major Businesses
Table 77. Merck & Alzheimer’s Therapeutics Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Merck & Product
Table 79. Merck & Recent Development
Table 80. Novartis AG Corporation Information
Table 81. Novartis AG Description and Major Businesses
Table 82. Novartis AG Alzheimer’s Therapeutics Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Novartis AG Product
Table 84. Novartis AG Recent Development
Table 85. Eisai Corporation Information
Table 86. Eisai Description and Major Businesses
Table 87. Eisai Alzheimer’s Therapeutics Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Eisai Product
Table 89. Eisai Recent Development
Table 90. H. Lundbeck A/S Corporation Information
Table 91. H. Lundbeck A/S Description and Major Businesses
Table 92. H. Lundbeck A/S Alzheimer’s Therapeutics Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. H. Lundbeck A/S Product
Table 94. H. Lundbeck A/S Recent Development
Table 95. AC Immune Corporation Information
Table 96. AC Immune Description and Major Businesses
Table 97. AC Immune Alzheimer’s Therapeutics Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. AC Immune Product
Table 99. AC Immune Recent Development
Table 100. TauRx Pharmaceuticals Corporation Information
Table 101. TauRx Pharmaceuticals Description and Major Businesses
Table 102. TauRx Pharmaceuticals Alzheimer’s Therapeutics Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. TauRx Pharmaceuticals Product
Table 104. TauRx Pharmaceuticals Recent Development
Table 105. Actavis plc. Corporation Information
Table 106. Actavis plc. Description and Major Businesses
Table 107. Actavis plc. Alzheimer’s Therapeutics Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Actavis plc. Product
Table 109. Actavis plc. Recent Development
Table 110. Forest Laboratories Corporation Information
Table 111. Forest Laboratories Description and Major Businesses
Table 112. Forest Laboratories Alzheimer’s Therapeutics Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Forest Laboratories Product
Table 114. Forest Laboratories Recent Development
Table 115. Teva Pharmaceuticals Industries Corporation Information
Table 116. Teva Pharmaceuticals Industries Description and Major Businesses
Table 117. Teva Pharmaceuticals Industries Alzheimer’s Therapeutics Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Teva Pharmaceuticals Industries Product
Table 119. Teva Pharmaceuticals Industries Recent Development
Table 120. Janssen Pharmaceutical Corporation Information
Table 121. Janssen Pharmaceutical Description and Major Businesses
Table 122. Janssen Pharmaceutical Alzheimer’s Therapeutics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Janssen Pharmaceutical Product
Table 124. Janssen Pharmaceutical Recent Development
Table 125. GE healthcare Corporation Information
Table 126. GE healthcare Description and Major Businesses
Table 127. GE healthcare Alzheimer’s Therapeutics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. GE healthcare Product
Table 129. GE healthcare Recent Development
Table 130. Eli Lilly And Company Corporation Information
Table 131. Eli Lilly And Company Description and Major Businesses
Table 132. Eli Lilly And Company Alzheimer’s Therapeutics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Eli Lilly And Company Product
Table 134. Eli Lilly And Company Recent Development
Table 135. DiaGenic ASA Corporation Information
Table 136. DiaGenic ASA Description and Major Businesses
Table 137. DiaGenic ASA Alzheimer’s Therapeutics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. DiaGenic ASA Product
Table 139. DiaGenic ASA Recent Development
Table 140. VTV Therapeutics Corporation Information
Table 141. VTV Therapeutics Description and Major Businesses
Table 142. VTV Therapeutics Alzheimer’s Therapeutics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. VTV Therapeutics Product
Table 144. VTV Therapeutics Recent Development
Table 145. Hoffman-La Roche Corporation Information
Table 146. Hoffman-La Roche Description and Major Businesses
Table 147. Hoffman-La Roche Alzheimer’s Therapeutics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Hoffman-La Roche Product
Table 149. Hoffman-La Roche Recent Development
Table 150. AstraZeneca Corporation Information
Table 151. AstraZeneca Description and Major Businesses
Table 152. AstraZeneca Alzheimer’s Therapeutics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. AstraZeneca Product
Table 154. AstraZeneca Recent Development
Table 155. Daiichi Sankyo Company Corporation Information
Table 156. Daiichi Sankyo Company Description and Major Businesses
Table 157. Daiichi Sankyo Company Alzheimer’s Therapeutics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 158. Daiichi Sankyo Company Product
Table 159. Daiichi Sankyo Company Recent Development
Table 160. Global Alzheimer’s Therapeutics Sales Forecast by Regions (2021-2026) (M Units)
Table 161. Global Alzheimer’s Therapeutics Sales Market Share Forecast by Regions (2021-2026)
Table 162. Global Alzheimer’s Therapeutics Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 163. Global Alzheimer’s Therapeutics Revenue Market Share Forecast by Regions (2021-2026)
Table 164. North America: Alzheimer’s Therapeutics Sales Forecast by Country (2021-2026) (M Units)
Table 165. North America: Alzheimer’s Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 166. Europe: Alzheimer’s Therapeutics Sales Forecast by Country (2021-2026) (M Units)
Table 167. Europe: Alzheimer’s Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 168. Asia Pacific: Alzheimer’s Therapeutics Sales Forecast by Region (2021-2026) (M Units)
Table 169. Asia Pacific: Alzheimer’s Therapeutics Revenue Forecast by Region (2021-2026) (US$ Million)
Table 170. Latin America: Alzheimer’s Therapeutics Sales Forecast by Country (2021-2026) (M Units)
Table 171. Latin America: Alzheimer’s Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 172. Middle East and Africa: Alzheimer’s Therapeutics Sales Forecast by Country (2021-2026) (M Units)
Table 173. Middle East and Africa: Alzheimer’s Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 174. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 175. Key Challenges
Table 176. Market Risks
Table 177. Main Points Interviewed from Key Alzheimer’s Therapeutics Players
Table 178. Alzheimer’s Therapeutics Customers List
Table 179. Alzheimer’s Therapeutics Distributors List
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Alzheimer’s Therapeutics Product Picture
Figure 2. Global Alzheimer’s Therapeutics Sales Market Share by Type in 2020 & 2026
Figure 3. Donepezil Product Picture
Figure 4. Memantine Product Picture
Figure 5. Rivastigmine Product Picture
Figure 6. Global Alzheimer’s Therapeutics Sales Market Share by Application in 2020 & 2026
Figure 7. Early to Moderate Stages
Figure 8. Moderate to Severe Stages
Figure 9. Alzheimer’s Therapeutics Report Years Considered
Figure 10. Global Alzheimer’s Therapeutics Market Size 2015-2026 (US$ Million)
Figure 11. Global Alzheimer’s Therapeutics Sales 2015-2026 (M Units)
Figure 12. Global Alzheimer’s Therapeutics Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Alzheimer’s Therapeutics Sales Market Share by Region (2015-2020)
Figure 14. Global Alzheimer’s Therapeutics Sales Market Share by Region in 2019
Figure 15. Global Alzheimer’s Therapeutics Revenue Market Share by Region (2015-2020)
Figure 16. Global Alzheimer’s Therapeutics Revenue Market Share by Region in 2019
Figure 17. Global Alzheimer’s Therapeutics Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Alzheimer’s Therapeutics Revenue in 2019
Figure 19. Alzheimer’s Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Alzheimer’s Therapeutics Sales Market Share by Type (2015-2020)
Figure 21. Global Alzheimer’s Therapeutics Sales Market Share by Type in 2019
Figure 22. Global Alzheimer’s Therapeutics Revenue Market Share by Type (2015-2020)
Figure 23. Global Alzheimer’s Therapeutics Revenue Market Share by Type in 2019
Figure 24. Global Alzheimer’s Therapeutics Market Share by Price Range (2015-2020)
Figure 25. Global Alzheimer’s Therapeutics Sales Market Share by Application (2015-2020)
Figure 26. Global Alzheimer’s Therapeutics Sales Market Share by Application in 2019
Figure 27. Global Alzheimer’s Therapeutics Revenue Market Share by Application (2015-2020)
Figure 28. Global Alzheimer’s Therapeutics Revenue Market Share by Application in 2019
Figure 29. North America Alzheimer’s Therapeutics Sales Growth Rate 2015-2020 (M Units)
Figure 30. North America Alzheimer’s Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Alzheimer’s Therapeutics Sales Market Share by Country in 2019
Figure 32. North America Alzheimer’s Therapeutics Revenue Market Share by Country in 2019
Figure 33. U.S. Alzheimer’s Therapeutics Sales Growth Rate (2015-2020) (M Units)
Figure 34. U.S. Alzheimer’s Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Alzheimer’s Therapeutics Sales Growth Rate (2015-2020) (M Units)
Figure 36. Canada Alzheimer’s Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Alzheimer’s Therapeutics Market Share by Type in 2019
Figure 38. North America Alzheimer’s Therapeutics Market Share by Application in 2019
Figure 39. Europe Alzheimer’s Therapeutics Sales Growth Rate 2015-2020 (M Units)
Figure 40. Europe Alzheimer’s Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Alzheimer’s Therapeutics Sales Market Share by Country in 2019
Figure 42. Europe Alzheimer’s Therapeutics Revenue Market Share by Country in 2019
Figure 43. Germany Alzheimer’s Therapeutics Sales Growth Rate (2015-2020) (M Units)
Figure 44. Germany Alzheimer’s Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Alzheimer’s Therapeutics Sales Growth Rate (2015-2020) (M Units)
Figure 46. France Alzheimer’s Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Alzheimer’s Therapeutics Sales Growth Rate (2015-2020) (M Units)
Figure 48. U.K. Alzheimer’s Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Alzheimer’s Therapeutics Sales Growth Rate (2015-2020) (M Units)
Figure 50. Italy Alzheimer’s Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Alzheimer’s Therapeutics Sales Growth Rate (2015-2020) (M Units)
Figure 52. Russia Alzheimer’s Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Alzheimer’s Therapeutics Market Share by Type in 2019
Figure 54. Europe Alzheimer’s Therapeutics Market Share by Application in 2019
Figure 55. Asia Pacific Alzheimer’s Therapeutics Sales Growth Rate 2015-2020 (M Units)
Figure 56. Asia Pacific Alzheimer’s Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Alzheimer’s Therapeutics Sales Market Share by Region in 2019
Figure 58. Asia Pacific Alzheimer’s Therapeutics Revenue Market Share by Region in 2019
Figure 59. China Alzheimer’s Therapeutics Sales Growth Rate (2015-2020) (M Units)
Figure 60. China Alzheimer’s Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Alzheimer’s Therapeutics Sales Growth Rate (2015-2020) (M Units)
Figure 62. Japan Alzheimer’s Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Alzheimer’s Therapeutics Sales Growth Rate (2015-2020) (M Units)
Figure 64. South Korea Alzheimer’s Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Alzheimer’s Therapeutics Sales Growth Rate (2015-2020) (M Units)
Figure 66. India Alzheimer’s Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Alzheimer’s Therapeutics Sales Growth Rate (2015-2020) (M Units)
Figure 68. Australia Alzheimer’s Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Alzheimer’s Therapeutics Sales Growth Rate (2015-2020) (M Units)
Figure 70. Taiwan Alzheimer’s Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Alzheimer’s Therapeutics Sales Growth Rate (2015-2020) (M Units)
Figure 72. Indonesia Alzheimer’s Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Alzheimer’s Therapeutics Sales Growth Rate (2015-2020) (M Units)
Figure 74. Thailand Alzheimer’s Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Alzheimer’s Therapeutics Sales Growth Rate (2015-2020) (M Units)
Figure 76. Malaysia Alzheimer’s Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Alzheimer’s Therapeutics Sales Growth Rate (2015-2020) (M Units)
Figure 78. Philippines Alzheimer’s Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Alzheimer’s Therapeutics Sales Growth Rate (2015-2020) (M Units)
Figure 80. Vietnam Alzheimer’s Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Alzheimer’s Therapeutics Market Share by Type in 2019
Figure 82. Asia Pacific Alzheimer’s Therapeutics Market Share by Application in 2019
Figure 83. Latin America Alzheimer’s Therapeutics Sales Growth Rate 2015-2020 (M Units)
Figure 84. Latin America Alzheimer’s Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Alzheimer’s Therapeutics Sales Market Share by Country in 2019
Figure 86. Latin America Alzheimer’s Therapeutics Revenue Market Share by Country in 2019
Figure 87. Mexico Alzheimer’s Therapeutics Sales Growth Rate (2015-2020) (M Units)
Figure 88. Mexico Alzheimer’s Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Alzheimer’s Therapeutics Sales Growth Rate (2015-2020) (M Units)
Figure 90. Brazil Alzheimer’s Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Alzheimer’s Therapeutics Sales Growth Rate (2015-2020) (M Units)
Figure 92. Argentina Alzheimer’s Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Alzheimer’s Therapeutics Market Share by Type in 2019
Figure 94. Latin America Alzheimer’s Therapeutics Market Share by Application in 2019
Figure 95. Middle East and Africa Alzheimer’s Therapeutics Sales Growth Rate 2015-2020 (M Units)
Figure 96. Middle East and Africa Alzheimer’s Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Alzheimer’s Therapeutics Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Alzheimer’s Therapeutics Revenue Market Share by Country in 2019
Figure 99. Turkey Alzheimer’s Therapeutics Sales Growth Rate (2015-2020) (M Units)
Figure 100. Turkey Alzheimer’s Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Alzheimer’s Therapeutics Sales Growth Rate (2015-2020) (M Units)
Figure 102. Saudi Arabia Alzheimer’s Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Alzheimer’s Therapeutics Sales Growth Rate (2015-2020) (M Units)
Figure 104. U.A.E Alzheimer’s Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Alzheimer’s Therapeutics Market Share by Type in 2019
Figure 106. Middle East and Africa Alzheimer’s Therapeutics Market Share by Application in 2019
Figure 107. North America Alzheimer’s Therapeutics Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 108. North America Alzheimer’s Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Alzheimer’s Therapeutics Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 110. Europe Alzheimer’s Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Alzheimer’s Therapeutics Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 112. Asia Pacific Alzheimer’s Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Alzheimer’s Therapeutics Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 114. Latin America Alzheimer’s Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Alzheimer’s Therapeutics Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 116. Middle East and Africa Alzheimer’s Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
アルツハイマー病の世界市場（～2026年） Market Analysis and Insights: Global Alzheimer's Disease Market The global Alzheimer's Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Alzheimer's Disease Scope and Market Size Alzheimer's Disease market is seg…- アルツハイマーの世界市場（～2026年） Alzheimer’s is a neurodegenerative progressive disease. Alzheimer's disease is a type of dementia whichludes a broad group of brain diseasessuch as problems with memorythinkingand behavior for the long term. It is a type of dementia and near about 60-70% of Alzheimer's disease is the cause of dement…
- アルツハイマー病治療の世界市場（～2026年） Market Analysis and Insights: Global Alzheimer’s Therapeutic Market The global Alzheimer’s Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Alzheimer’s Therapeutic Scope and Market Size Alzheimer’s Therapeut…
- 全身性乾癬治療薬の世界市場（～2026年） Psoriasis is an autoimmune skin disease that causes scaling, skin redness and irritation. Psoriasis causes red, scaly patches that are generally found on the elbows, fingernails, scalp, palms, knees, face, feet and inside the mouth. Factors that can trigger psoriasis include infections, heavy alcoho…
- 肺がん治療薬の世界市場（～2026年） Market Analysis and Insights: Global Lung Cancer Therapeutics Market The global Lung Cancer Therapeutics market size is projected to reach US$ 15800 million by 2026, from US$ 14180 million in 2020, at a CAGR of 10.6%% during 2021-2026. Global Lung Cancer Therapeutics Scope and Market Size Lung Cance…